Shannon Leigh Walston

Shannon Leigh Walston

Auto-generated profile, based on publicly available information

Shannon Leigh Walston

Department of Artificial Intelligence, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2025 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
HTHirotaka Takita
Hirotaka Takita
DKDaijiro Kabata
Daijiro Kabata
SWShannon L. Walston
Shannon L. Walston
HTHiroyuki Tatekawa
Hiroyuki Tatekawa
KSKenichi Saito
Kenichi Saito
DUDaiju Ueda
Daiju Ueda
While generative artificial intelligence (AI) has shown potential in medical diagnostics, comprehensive evaluation of its diagnostic performance and comparison with physicians has not been extensively explored. We conducted a systematic review and meta-analysis of studies validating generative AI models for diagnostic tasks published between June 2018 and June 2024. Analysis of 83 studies revealed an overall diagnostic accuracy of 52.1%. No significant performance difference was found between AI models and physicians overall (p = 0.10) or non-expert physicians (p = 0.93). However, AI models performed significantly worse than expert physicians (p = 0.007). Several models demonstrated slightly higher performance compared to non-experts, although the differences were not significant. Generative AI demonstrates promising diagnostic capabilities with accuracy varying by model. Although it has not yet achieved expert-level reliability, these findings suggest potential for enhancing healthcare delivery and medical education when implemented with appropriate understanding of its limitations.

1 July 2023 in Radiology
Verified
Journal Article
Closed access
DUDaiju Ueda
Daiju Ueda
YMYasuhito Mitsuyama
Yasuhito Mitsuyama
HTHirotaka Takita
Hirotaka Takita
DHDaisuke Horiuchi
Daisuke Horiuchi
SWShannon L. Walston
Shannon L. Walston
YMYukio Miki
Yukio Miki

23 November 2023 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
DHDaisuke Horiuchi
Daisuke Horiuchi
HTHiroyuki Tatekawa
Hiroyuki Tatekawa
TSTaro Shimono
Taro Shimono
SWShannon L Walston
Shannon L Walston
HTHirotaka Takita
Hirotaka Takita
DUDaiju Ueda
Daiju Ueda

28 May 2024 in Clinical Neuroradiology
Verified
Journal Article
Closed access
PDF file
DHDaisuke Horiuchi
Daisuke Horiuchi
HTHiroyuki Tatekawa
Hiroyuki Tatekawa
TOTatsushi Oura
Tatsushi Oura
SOSatoshi Oue
Satoshi Oue
SWShannon L Walston
Shannon L Walston
DUDaiju Ueda
Daiju Ueda

1 June 2021 in Radiology
Verified
Journal Article
Closed access
DUDaiju Ueda
Daiju Ueda
YKYutaka Katayama
Yutaka Katayama
AYAkira Yamamoto
Akira Yamamoto
TITsutomu Ichinose
Tsutomu Ichinose
HAHironori Arima
Hironori Arima
YMYukio Miki
Yukio Miki
A deep learning–based model generated cerebral angiograms free from clinically significant misregistration that were equivalent to or better than digital subtraction angiograms both quantitatively ... Background Digital subtraction angiography (DSA) generates an image by subtracting a mask image from a dynamic angiogram. However, patient movement–caused misregistration artifacts can result in un...

1 August 2023 in Radiology
Verified
Journal Article
Closed access
HTHirotaka Takita
Hirotaka Takita
TMToshimasa Matsumoto
Toshimasa Matsumoto
HTHiroyuki Tatekawa
Hiroyuki Tatekawa
YKYutaka Katayama
Yutaka Katayama
KNKosuke Nakajo
Kosuke Nakajo
DUDaiju Ueda
Daiju Ueda
Background Carbon 11 (11C)-methionine is a useful PET radiotracer for the management of patients with glioma, but radiation exposure and lack of molecular imaging facilities limit its use. Purpose To generate synthetic methionine PET images from contrast-enhanced (CE) MRI through an artificial intelligence (AI)-based image-to-image translation model and to compare its performance for grading and prognosis of gliomas with that of real PET. Materials and Methods An AI-based model to generate synthetic methionine PET images from CE MRI was developed and validated from patients who underwent both methionine PET and CE MRI at a university hospital from January 2007 to December 2018 (institutional data set). Pearson correlation coefficients for the maximum and mean tumor to background ratio (TBRmax and TBRmean, respectively) of methionine uptake and the lesion volume between synthetic and real PET were calculated. Two additional open-source glioma databases of preoperative CE MRI without methionine PET were used as the external test set. Using the TBRs, the area under the receiver operating characteristic curve (AUC) for classifying high-grade and low-grade gliomas and overall survival were evaluated. Results The institutional data set included 362 patients (mean age, 49 years ± 19 [SD]; 195 female, 167 male; training, n = 294; validation, n = 34; test, n = 34). In the internal test set, Pearson correlation coefficients were 0.68 (95% CI: 0.47, 0.81), 0.76 (95% CI: 0.59, 0.86), and 0.92 (95% CI: 0.85, 0.95) for TBRmax, TBRmean, and lesion volume, respectively. The external test set included 344 patients with gliomas (mean age, 53 years ± 15; 192 male, 152 female; high grade, n = 269). The AUC for TBRmax was 0.81 (95% CI: 0.75, 0.86) and the overall survival analysis showed a significant difference between the high (2-year survival rate, 27%) and low (2-year survival rate, 71%; P < .001) TBRmax groups. Conclusion The AI-based model-generated synthetic methionine PET images strongly correlated with real PET images and showed good performance for glioma grading and prognostication. Published under a CC BY 4.0 license. Supplemental material is available for this article.